Literature DB >> 7405203

Tubo-ovarian Actinomycosis and the Use of Intrauterine Devices.

R McLeod, S Smith, T E Poore, J L Lindsey, J S Remington.   

Abstract

Entities:  

Keywords:  Contraception; Contraceptive Methods--complications; Diseases; Family Planning; Female Sterilization; Gynecologic Surgery; Infections; Iud--complications; Laparotomy; Pelvic Infections; Surgery; Treatment

Mesh：

Year:  1980        PMID： 7405203      PMCID： PMC1272160     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  19 in total

1.  Tubo-ovarian actinomycosis associated with intrauterine contraceptive devices.

Authors:  F E Dische; L J Burt; N J Davidson; S Puntambekar
Journal:  J Obstet Gynaecol Br Commonw       Date:  1974-09

2.  Characterization of actinomycotic granules by architecture and staining methods.

Authors:  M Hotchi; J Schwarz
Journal:  Arch Pathol       Date:  1972-05

3.  Actinomycosis of the female genital organs.

Authors:  G O Richter; J H Pratt; D R Nichols; C B Coulam
Journal:  Minn Med       Date:  1972-11

4.  Pelvic actinomycosis associated with an intrauterine device.

Authors:  S R Henderson
Journal:  Obstet Gynecol       Date:  1973-05       Impact factor: 7.661

5.  Human actinomycosis. A study of 181 subjects.

Authors:  J R Brown
Journal:  Hum Pathol       Date:  1973-09       Impact factor: 3.466

6.  Sulfur granules. Second thoughts.

Authors:  J R Graybill; B D Silverman
Journal:  Arch Intern Med       Date:  1969-04

7.  Pelvic actinomycosis in the presence of an endocervical contraceptive device. Report of a case.

Authors:  R W Brenner; S W Gehring
Journal:  Obstet Gynecol       Date:  1967-01       Impact factor: 7.661

8.  Actinomycosis infections associated with intrauterine contraceptive devices.

Authors:  M A Schiffer; A Elguezabal; M Sultana; A C Allen
Journal:  Obstet Gynecol       Date:  1975-01       Impact factor: 7.661

9.  Serological studies of Actinomyces israelii by crossed immunoelectrophoresis: taxonomic and diagnostic applications.

Authors:  K Holmberg; C E Nord; T Wadström
Journal:  Infect Immun       Date:  1975-08       Impact factor: 3.441

10.  Susceptibility of pathogenic actinomycetes to antimicrobial compounds.

Authors:  P I Lerner
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191
View more
  2 in total

1.  Actinomyces naeslundii as an agent of pelvic actinomycosis in the presence of an intrauterine device.

Authors:  W Bonnez; G Lattimer; N A Mohanraj; T H Johnson
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

Review 2.  Pelvic Actinomycosis.

Authors:  Alejandra García-García; Ninfa Ramírez-Durán; Horacio Sandoval-Trujillo; María Del Socorro Romero-Figueroa
Journal:  Can J Infect Dis Med Microbiol       Date:  2017-06-08       Impact factor: 2.471
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.